Phase II Clinical Trials: D-methionine to Reduce Noise-Induced Hearing Loss
Abstract
The purpose of this Phase 2 clinical trial is to determine if an oral, orange flavored suspension of D-methionine can prevent noise-induced hearing loss (NIHL) and tinnitus in our troops.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2012
- Accession Number
- ADA563502
Entities
People
- Kathleen C. Campbell
Organizations
- Southern Illinois University School of Medicine